Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
23 1월 2024 - 10:30PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to
release its fourth quarter and fiscal year 2023 financial results
after market close on Thursday, February 8, 2024. Management will
hold a conference call to review the company's fourth quarter and
fiscal year 2023 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on the Dexcom investor
relations website at investors.dexcom.com and will be archived
there for future reference.
To listen to the conference call, please dial (888) 414-4585
(US/Canada) or (646) 960-0331 (International) and use the
confirmation ID "9430114" approximately five minutes prior to the
start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, Calif., and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom works to simplify and
improve diabetes management around the world. For more information
about Dexcom CGM, visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240123149570/en/
DexCom, Inc.: Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024